Sernova (TSE:SVA) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sernova Corp., a clinical-stage biotech firm, will be featured at the Cell & Gene Meeting on the Mesa where CEO Jonathan Rigby will present advances in cell therapy, including their ongoing diabetes clinical trial and collaborative pre-clinical work for a potential diabetes cure. The company is known for developing the Cell Pouch Transplant System aiming to provide a ‘functional cure’ for diabetes and other chronic diseases through cell therapy.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.